487 related articles for article (PubMed ID: 15084276)
41. Transcriptional control of invariant NKT cell development.
Das R; Sant'Angelo DB; Nichols KE
Immunol Rev; 2010 Nov; 238(1):195-215. PubMed ID: 20969594
[TBL] [Abstract][Full Text] [Related]
42. The gene encoding early growth response 2, a target of the transcription factor NFAT, is required for the development and maturation of natural killer T cells.
Lazarevic V; Zullo AJ; Schweitzer MN; Staton TL; Gallo EM; Crabtree GR; Glimcher LH
Nat Immunol; 2009 Mar; 10(3):306-13. PubMed ID: 19169262
[TBL] [Abstract][Full Text] [Related]
43. Critical role of ROR-γt in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation.
Michel ML; Mendes-da-Cruz D; Keller AC; Lochner M; Schneider E; Dy M; Eberl G; Leite-de-Moraes MC
Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19845-50. PubMed ID: 19057011
[TBL] [Abstract][Full Text] [Related]
44. The transcription factor PLZF directs the effector program of the NKT cell lineage.
Savage AK; Constantinides MG; Han J; Picard D; Martin E; Li B; Lantz O; Bendelac A
Immunity; 2008 Sep; 29(3):391-403. PubMed ID: 18703361
[TBL] [Abstract][Full Text] [Related]
45. Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development.
Griewank K; Borowski C; Rietdijk S; Wang N; Julien A; Wei DG; Mamchak AA; Terhorst C; Bendelac A
Immunity; 2007 Nov; 27(5):751-62. PubMed ID: 18031695
[TBL] [Abstract][Full Text] [Related]
46. Control points in NKT-cell development.
Godfrey DI; Berzins SP
Nat Rev Immunol; 2007 Jul; 7(7):505-18. PubMed ID: 17589542
[TBL] [Abstract][Full Text] [Related]
47. DX5/CD49b-positive T cells are not synonymous with CD1d-dependent NKT cells.
Pellicci DG; Hammond KJ; Coquet J; Kyparissoudis K; Brooks AG; Kedzierska K; Keating R; Turner S; Berzins S; Smyth MJ; Godfrey DI
J Immunol; 2005 Oct; 175(7):4416-25. PubMed ID: 16177083
[TBL] [Abstract][Full Text] [Related]
48. Lymphotoxin alpha 1 beta 2: a critical mediator in V alpha 14i NKT cell differentiation.
Franki AS; Van Beneden K; Dewint P; Meeus I; Veys E; Deforce D; Elewaut D
Mol Immunol; 2005 Feb; 42(4):413-7. PubMed ID: 15607792
[TBL] [Abstract][Full Text] [Related]
49. Eomesodermin and T-bet mark developmentally distinct human natural killer cells.
Collins A; Rothman N; Liu K; Reiner SL
JCI Insight; 2017 Mar; 2(5):e90063. PubMed ID: 28289707
[TBL] [Abstract][Full Text] [Related]
50. T-bet: a bridge between innate and adaptive immunity.
Lazarevic V; Glimcher LH; Lord GM
Nat Rev Immunol; 2013 Nov; 13(11):777-89. PubMed ID: 24113868
[TBL] [Abstract][Full Text] [Related]
51. T-bet and Eomes govern differentiation and function of mouse and human NK cells and ILC1.
Zhang J; Marotel M; Fauteux-Daniel S; Mathieu AL; Viel S; Marçais A; Walzer T
Eur J Immunol; 2018 May; 48(5):738-750. PubMed ID: 29424438
[TBL] [Abstract][Full Text] [Related]
52. T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3.
Hwang ES; Szabo SJ; Schwartzberg PL; Glimcher LH
Science; 2005 Jan; 307(5708):430-3. PubMed ID: 15662016
[TBL] [Abstract][Full Text] [Related]
53. A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127.
Vosshenrich CA; García-Ojeda ME; Samson-Villéger SI; Pasqualetto V; Enault L; Richard-Le Goff O; Corcuff E; Guy-Grand D; Rocha B; Cumano A; Rogge L; Ezine S; Di Santo JP
Nat Immunol; 2006 Nov; 7(11):1217-24. PubMed ID: 17013389
[TBL] [Abstract][Full Text] [Related]
54. Inflammatory-driven NK cell maturation and its impact on pathology.
Bourayou E; Golub R
Front Immunol; 2022; 13():1061959. PubMed ID: 36569860
[TBL] [Abstract][Full Text] [Related]
55. Tissue-Resident NK Cells: Development, Maturation, and Clinical Relevance.
Hashemi E; Malarkannan S
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32545516
[TBL] [Abstract][Full Text] [Related]
56. Deciphering Natural Killer Cell Homeostasis.
Pfefferle A; Jacobs B; Haroun-Izquierdo A; Kveberg L; Sohlberg E; Malmberg KJ
Front Immunol; 2020; 11():812. PubMed ID: 32477340
[TBL] [Abstract][Full Text] [Related]
57. Innate lymphoid cells--how did we miss them?
Walker JA; Barlow JL; McKenzie AN
Nat Rev Immunol; 2013 Feb; 13(2):75-87. PubMed ID: 23292121
[TBL] [Abstract][Full Text] [Related]
58. The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions.
Kovalovsky D; Uche OU; Eladad S; Hobbs RM; Yi W; Alonzo E; Chua K; Eidson M; Kim HJ; Im JS; Pandolfi PP; Sant'Angelo DB
Nat Immunol; 2008 Sep; 9(9):1055-64. PubMed ID: 18660811
[TBL] [Abstract][Full Text] [Related]
59. Flexible modeling of regulatory networks improves transcription factor activity estimation.
Chen C; Padi M
NPJ Syst Biol Appl; 2024 May; 10(1):58. PubMed ID: 38806476
[TBL] [Abstract][Full Text] [Related]
60. Group 1 ILCs: Heterogeneity, plasticity, and transcriptional regulation.
Sudan R; Gilfillan S; Colonna M
Immunol Rev; 2024 May; 323(1):107-117. PubMed ID: 38563448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
